Canon Kabushiki Kaisha

Sbi Pharmaceuticals Co., Ltd.

National Center for Child Health and Development

The University of Tokyo

Reprocell, Inc.

Hidenori Ito

Tohru Tanaka

Motowo Nakajima

Kiwamu Takahashi

Fuminori Abe

Ko Rii

Naomi Haga

Kiwamu Kobayashi

Jun Abe

Kouji Matsushima

Yasufumi Takama

Hiroyuki Ishikawa

Satoshi Ueha

Shunsuke Yoshida

Mitsuru Inamura

In order to extract a foreground area more appropriately, an image processing apparatus for extracting a foreground area from an inputted image includes an image input unit that sets a first area and a second area different from the first area in the inputted image, a first extraction unit that extracts a foreground area from the first area, and a second extraction unit that extracts a foreground area from the second area by using an extraction method different from an extraction method used by the first extraction unit.

Image processing apparatus, image processing method, and storage medium

A pose estimation apparatus () obtains a plurality of images captured by a plurality of image capturing apparatuses () from different directions, specifies an image that is to be used for generating a three-dimensional pose model indicating a plurality of joint positions of an object, from the plurality of images, and generates a three-dimensional pose model of the object based on the specified image.

Pose generation apparatus, generation method, and storage medium

A stem cell removing method that certainly-removes an undifferentiated stem cell is provided. For this object, a cell group including a stem cell and a somatic cell performed differentiation induction is cultivated in culture medium composition including photosensitizer. Light of a specific wavelength is irradiated with the cell group, and the stem cell is removed, selectively. The stem cell is a pluripotent stem cell or a somatic stem cell. The pluripotent stem cell includes either an ES cell (Embryonic Stem Cell) or an iPS cell (induced Pluripotent Stem Cell). Also, somatic stem cell includes any one of a germ stem cell, a productive cell, a pluripotent stem cell and a stem cell having unipotency.

Method of removing pluripotent cells from culture

The object of the invention is to provide a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor. Provided is a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor comprising 5-aminolevulinic acids (ALAs) as the active ingredient.

Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor

An image processing apparatus in an image processing system configured to generate a virtual point image using a plurality of images captured by a plurality of image capturing apparatus receives a first difference image being based on a difference between a third image based on image capturing performed by a third image capturing apparatus of the plurality of image capturing apparatuses and a second image based on image capturing performed by a second image capturing apparatus of the plurality of image capturing apparatuses and has a smaller data amount than that of the third image, and acquires a foreground image by extracting a predetermined object from the second image, using the received first difference image and a second difference image between a first image based on image capturing performed by a first image capturing apparatus of the plurality of image capturing apparatus and the second image.

An image processing apparatus includes a display control unit configured to scroll a plurality of pieces of content data, a prediction unit configured to predict which content data among the plurality of pieces of content data moves from a hidden area to a display area according to a scroll display control condition controlled by the display control unit, and a decoding unit configured to decode the content data predicted by the prediction unit before the predicted content data moves to the display area.

Image processing apparatus, image processing method, and program

A projection apparatus among a plurality of projection apparatuses for executing multi-projection includes a holding unit configured to hold setting information about a role of the projection apparatus among the plurality of projection apparatuses for executing the multi-projection, a reception unit configured to receive an instruction for displaying a menu screen for changing a setting of the projection apparatus, a determination unit configured to determine whether to display the menu screen upon reception of the instruction by the reception unit, based on the setting information held by the holding unit, and a projection unit configured to project the menu screen according to a result of determination by the determination unit.

Projection system, projection apparatus, information processing method, and storage medium

The present invention provides an agent for promoting graft survival which can suppress rejection without use of existing immunosuppressants, an organ preservation solution capable of maintaining the freshness of an organ excised from a donor, and the like. An agent for promoting graft survival or an organ preservation solution is prepared, which comprises 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of ALA or the derivative and an iron compound as active ingredients. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Enhancer of survival of transplanted organ

An object of the present invention is to provide a preventive and/or therapeutic agent for radiation damage that has a novel mechanism of action and can prevent and alleviate a wide range of symptoms of radiation damage for which no therapeutic measures have been available so far, and moreover, is highly safe to humans. A preventive and/or therapeutic agent for radiation damage comprising a compound represented by the following formula (I) such as 5-aminolevulinic acid (5-ALA) or a salt thereof as an active ingredient can be used to improve the survival rate, improve body weight reduction, and alleviate hematopoietic disorder: (wherein Rrepresents a hydrogen atom or an acyl group; and Rrepresents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group).

Prophylactic and/or therapeutic agent for radiation damage

An object of the present invention is to provide a regulatory dendritic cell inducing agent applicable to the treatment of immune disease as well as an immune tolerance inducing agent such as a preventive and/or therapeutic agent for allergic disease and a preventive and/or therapeutic agent for autoimmune disease, both of which are safe and have the mechanism of action different from that of conventional drugs. As a means for achieving the above object, an immune tolerance inducing agent comprising 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of the 5-ALA or the derivative and an iron compound as active ingredients is prepared. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Growing community of inventors

Tokyo, Japan

Hidenori Ito